BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37378746)

  • 1. Drug induced nephrotoxicity- A mechanistic approach.
    Sharma V; Singh TG
    Mol Biol Rep; 2023 Aug; 50(8):6975-6986. PubMed ID: 37378746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Synopsis of Current Theories on Drug-Induced Nephrotoxicity.
    Dobrek L
    Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology behind Common Drug Nephrotoxicities.
    Perazella MA
    Clin J Am Soc Nephrol; 2018 Dec; 13(12):1897-1908. PubMed ID: 29622670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the emerging role of transporters in the assessment of nephrotoxicity.
    Chen Y; Lu S; Zhang Y; Chen B; Zhou H; Jiang H
    Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):787-804. PubMed ID: 36420583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.
    Wu H; Huang J
    Curr Drug Metab; 2018; 19(7):559-567. PubMed ID: 29119923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach.
    Antognini N; Portman R; Dong V; Webb NJ; Chand DH
    Ther Innov Regul Sci; 2024 Mar; 58(2):286-302. PubMed ID: 38110788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies.
    Džidić-Krivić A; Sher EK; Kusturica J; Farhat EK; Nawaz A; Sher F
    Chem Biol Interact; 2024 Jan; 388():110838. PubMed ID: 38104745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-Induced Nephrotoxicity in Older Patients.
    Fusco S; Garasto S; Corsonello A; Vena S; Mari V; Gareri P; Ruotolo G; Luciani F; Roncone A; Maggio M; Lattanzio F
    Curr Drug Metab; 2016; 17(6):608-25. PubMed ID: 27048182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity.
    Connor S; Li T; Qu Y; Roberts RA; Tong W
    Drug Discov Today; 2024 Apr; 29(4):103938. PubMed ID: 38432353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mechanism of Drug Nephrotoxicity and the Methods for Preventing Kidney Damage.
    Kwiatkowska E; Domański L; Dziedziejko V; Kajdy A; Stefańska K; Kwiatkowski S
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal function and pharmacotherapy in children].
    Jovanović O
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced nephrotoxicity. Aetiology, clinical features and management.
    Hoitsma AJ; Wetzels JF; Koene RA
    Drug Saf; 1991; 6(2):131-47. PubMed ID: 2043284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicologic Pathology Forum Opinion Paper*: Recommendations for a Tiered Approach to Nonclinical Mechanistic Nephrotoxicity Evaluation.
    Ennulat D; Ringenberg M; Frazier KS
    Toxicol Pathol; 2018 Aug; 46(6):636-646. PubMed ID: 30049250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer drug-induced kidney disorders.
    Kintzel PE
    Drug Saf; 2001 Jan; 24(1):19-38. PubMed ID: 11219485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney Drug Transporters in Pharmacotherapy.
    Łapczuk-Romańska J; Droździk M; Oswald S; Droździk M
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside nephrotoxicity.
    Appel GB
    Am J Med; 1990 Mar; 88(3C):16S-20S; discussion 38S-42S. PubMed ID: 2180292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial-induced nephrotoxicity in the newborn.
    Fanos V; Cataldi L
    Drug Saf; 1999 Mar; 20(3):245-67. PubMed ID: 10221854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model.
    Carlos CP; Sonehara NM; Oliani SM; Burdmann EA
    PLoS One; 2014; 9(7):e103660. PubMed ID: 25072153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models.
    Tiong HY; Huang P; Xiong S; Li Y; Vathsala A; Zink D
    Mol Pharm; 2014 Jul; 11(7):1933-48. PubMed ID: 24502545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of MATE1 Inhibition and Cytotoxicity in Nephrotoxicity: Application for Safety Evaluation in Early Drug Discovery.
    Tohyama K; Chisaki I; Takai Y; Handa Y; Miyamoto M; Amano N
    Toxicol Sci; 2019 Jul; 170(1):223-233. PubMed ID: 31020312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.